Comments
Loading...
Fortress Biotech (FBIO) Forecast
NewsEarningsFortress Biotech (FBIO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestFortress Biotech (NASDAQ:FBIO) Stock Quotes, Forecast and News Summary
Fortress Biotech Stock (NASDAQ: FBIO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Fortress Biotech (FBIO) stock?
You can purchase shares of Fortress Biotech (NASDAQ:FBIO) through any online brokerage.
Who are Fortress Biotech (FBIO) competitors?
Other companies in Fortress Biotech’s space includes: Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), FibroGen (NASDAQ:FGEN), Barinthus Biotherapeutics (NASDAQ:BRNS) and Elicio Therapeutics (NASDAQ:ELTX).
What is the forecast, or price target, for Fortress Biotech (FBIO) stock?
Fortress Biotech has a consensus price target of $10.43.
What is the current price for Fortress Biotech (FBIO)?
The stock price for Fortress Biotech (NASDAQ: FBIO) is $2.13 last updated January 2, 2025 at 12:46 PM EST.
Does Fortress Biotech (FBIO) pay a dividend?
There are no upcoming dividends for Fortress Biotech.
When is Fortress Biotech (NASDAQ:FBIO) reporting earnings?
Fortress Biotech’s Q4 earnings are confirmed for Thursday, March 27, 2025.
Is Fortress Biotech (FBIO) going to split?
There is no upcoming split for Fortress Biotech.
What sector and industry does Fortress Biotech (FBIO) operate in?
Fortress Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.